Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Genes and microbes converge in colitis: Both host genetics and intestinal microbes probably contribute to a person's overall susceptibility to inflammatory bowel disease (IBD). The human gut microbe Bacteroides fragilis produces immunomodulatory molecules that it releases via outer membrane vesicles (OMVs). These molecules can protect mice from experimentally induced colitis. Chu et al. now find that OMV-mediated protection from colitis requires Atg16l1 and Nod2 genes whose human orthologs are associated with an increased risk for developing IBD. OMVs trigger an ATG16L1 and NOD2–dependent noncanonical autophagy pathway in dendritic cells (DCs). OMV-primed DCs, in turn, induce regulatory T cells in the intestine that protect against colitis. Science , this issue p. 1116
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“commensal Bacteroides fragilis‐induced activation of LAP drives a transcriptionally tolerogenic program of differentiation in antigen‐presenting cells, which is required to generate immunosuppressive TREG cells in the context of colitis (Chu et al, 2016).”
From Autophagy in major human diseases (2021) · cites this paper as Chu et al, 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Martinez, J., Malireddi, R. K. S., Lu, Q., Cunha, L. D., Pelletier, S., Gingras, S., Orchard, R., Guan, J.-L., Tan, H., Peng, J., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3192 · Cited by 758 · cited 12×
“Data are representative of at least three independent experiments, with three to nine mice per group. a known product of LAP activation (36), but at significantly reduced levels in Nod2−/− or Tlr2−/− DCs (fig.”
BackgroundInfluentialSelf-citationRetractedGenome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385 · cited 2×
“Intestinal microbiota modulate development and function of the immune system, and play a critical role in inflammatory bowel disease (IBD), a family of idiopathic intestinal disorders including Crohn’s disease (CD) and ulcerative colitis (UC) (1-6).”
BackgroundA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., Benchimol, E. I., Panaccione, R., Ghosh, S., Barkema, H. W., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.10.001 · Cited by 4,833
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
The International IBD Genetics Consortium (IIBDGC), Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Philip Schumm, L., Sharma, Y., et al. (2012) · Nature · doi:10.1038/nature11582 · Cited by 4,722 · cited 2×
“published online EpubJan (S0016-5085(11)01378-3 [pii]10.”
Self-citationInteractions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 2×
“Intestinal microbiota modulate development and function of the immune system, and play a critical role in inflammatory bowel disease (IBD), a family of idiopathic intestinal disorders including Crohn’s disease (CD) and ulcerative colitis (UC) (1-6).”
BackgroundAntimicrobial Autophagy: A Conserved Innate Immune Response in Drosophila
Moy, R. H., & Cherry, S. (2013) · Journal of Innate Immunity · doi:10.1159/000350326 · Cited by 3,539
A microbial symbiosis factor prevents intestinal inflammatory disease
Mazmanian, S. K., Round, J. L., & Kasper, D. L. (2008) · Nature · doi:10.1038/nature07008 · Cited by 2,340 · cited 1×
“fragilis capsular Polysaccharide A (PSA) is packaged in outer membrane vesicles (OMVs) and delivered to intestinal dendritic cells to induce interleukin-10 (IL-10) production from CD4+Foxp3+ regulatory T cells (Tregs), which protect from experimental colitis (30-32).”
BackgroundSelf-citation
Cited by
Items 201–300 of 645
Liu, Y., Huang, J., Li, S., Li, Z., Chen, C., Qu, G., Chen, K., Teng, Y., Ma, R., Wu, X., et al. (2023) · Biomaterials Science · doi:10.1039/d3bm01645e · Cited by 64
Wilkinson, H. N., Iveson, S., Catherall, P., & Hardman, M. J. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01450 · Cited by 64
“aeruginosa, these virulence factors include the endoproteases elastase (LasB) and alkaline protease (AprA), and alginate (AlgD; Goodman and Lory, 2004; Chu et al., 2016).”
BackgroundCao, Q., Gao, X., Lin, Y., Yue, C., Wang, Y., Quan, F., Zhang, Z., Liu, X., Lu, Y., Zhan, Y., et al. (2019) · Theranostics · doi:10.7150/thno.35015 · Cited by 59
“IL-22 is known to enhance the antibacterial defense of mucosal epithelial cells through different mechanisms [24], and UC is inextricably linked to the gut microbiome [25, 26].”
BackgroundThe Double Game Played by Th17 Cells in Infection: Host Defense and Immunopathology
Paroli, M., Caccavale, R., Fiorillo, M. T., Spadea, L., Gumina, S., Candela, V., & Paroli, M. P. (2022) · Pathogens · doi:10.3390/pathogens11121547 · Cited by 62
Exploring the microbiome in health and disease: Implications for toxicology
Scotti, E., Boué, S., Sasso, G. L., Zanetti, F., Belcastro, V., Poussin, C., Sierro, N., Battey, J. N. D., Gimalac, A., Ivanov, N. V., et al. (2017) · Toxicology Research and Application · doi:10.1177/2397847317741884 · Cited by 97
Genetic effects on the commensal microbiota in inflammatory bowel disease patients
Aschard, H., Laville, V., Tchetgen, E. T., Knights, D., Imhann, F., Seksik, P., Zaitlen, N., Silverberg, M. S., Cosnes, J., Weersma, R. K., et al. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008018 · Cited by 61
“Similarly, another study explored potential gene-microbiota interactions in the pathogenesis of IBD [10].”
BackgroundSelf-citationXia, X., Zhang, Y., Zhu, L., Yin, Y., Hao, W., Wang, L., He, L., Zhao, D., Chen, J., Gao, Y., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155039 · Cited by 57
Nazimek, K., Bryniarski, K., & Askenase, P. W. (2016) · International Archives of Allergy and Immunology · doi:10.1159/000449249 · Cited by 60
Kelly, C. J., Alexeev, E. E., Farb, L., Vickery, T. W., Zheng, L., Campbell, E. L., Kitzenberg, D., Battista, K. D., Kominsky, D. J., Robertson, C. E., et al. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1597667 · Cited by 68
“fragilis is protective in DSS colitis,(27) likely through immunomodulatory influences of its capsular polysaccharide-A(28) and modulating secreted outer membrane vesicles.(29) Given this selective decrease of Bacteroides, we subjected B12 supplemented mice to DSS colitis to evaluate their susceptibility to disease.”
MethodShu, G., Kong, F., Xu, D., Yin, L., He, C., Lin, J., Fu, H., Wang, K., Tian, Y., & Zhao, X. (2020) · Scientific Reports · doi:10.1038/s41598-020-69010-1 · Cited by 56
Gut microbiota and inflammatory bowel disease: The current status and perspectives
Zheng, L., & Wen, X. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i2.321 · Cited by 56
The gut virome in inflammatory bowel diseases
Liang, G., Güemes, A. G. C., Albenberg, L. G., & Bushman, F. D. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.10.005 · Cited by 55
Wang, T., Mo, L., Ou, J., Fang, Q., Wu, H., Wu, Y., & Nandakumar, K. S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.833040 · Cited by 64
Wei, S., Zhang, J., Wu, X., Chen, M., Huang, H., Zeng, S., Xiang, Z., Li, X., & Dong, W. (2022) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izac177 · Cited by 57
Yılmaz, B., Spalinger, M. R., Biedermann, L., Franc, Y., Fournier, N., Rossel, J., Juillerat, P., Rogler, G., Macpherson, A. J., & Scharl, M. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199664 · Cited by 58
“Nevertheless, more and more evidence suggests that genetic IBD risk factors, in particular NOD2 and ATG16L1, critically interact with the intestinal microbiota to maintain intestinal homeostasis and to control immune responses in the gastrointestinal tract [10, 11].”
BackgroundDetection of Bacterial Membrane Vesicles by NOD-Like Receptors
Johnston, E. L., Heras, B., Kufer, T. A., & Kaparakis‐Liaskos, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031005 · Cited by 51
“This study highlights the contribution of NOD2 and ATG16L1 to the production of antiinflammatory responses mediated by commensal OMVs and has significant implications for the NLR field due to the association of these host proteins in IBD [67].”
BackgroundInfluentialLopes, F., Keita, Å. V., Saxena, A., Reyes, J. L., Mancini, N. L., Al Rajabi, A., Wang, A., Baggio, C. H., Dicay, M., van Dalen, R., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000809 · Cited by 52
“Autophagy is important in host defense, where, for example, protection against colitis by outer membrane vesicles from Bacteroides fragilis requires ATG16L1-competent dendritic cells (30).”
BackgroundCommensal bacteria promote type I interferon signaling to maintain immune tolerance in mice
Ayala, A. V., Hsu, C.-Y., Oles, R. E., Matsuo, K., Loomis, L. R., Buzun, E., Terrazas, M. C., Gerner, R. R., Lu, H.-H., Kim, S., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20230063 · Cited by 66
“The induction of IL-10 by B. fragilis has been well established (Round et al., 2011; Shen et al., 2012; Chu et al., 2016); however, this data reveals the essential role of commensal-induced IFN signaling among DCs to promote tolerogenic responses.”
BackgroundMethodResultInfluentialSelf-citationLiang, D., Shen, X., Han, L., Ren, H., Zang, T., Tan, L., Lu, Z., Liao, X., Vetha, B. S. S., Liu, Y., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303016 · Cited by 51
Chen, C.-Y., Wang, Y., Lei, L., & Zhang, Y. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122815 · Cited by 60
Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD—What, Why, and How
Fiocchi, C., Dragoni, G., Iliopoulos, D., Katsanos, K. H., Hernández, V., Suzuki, K., Verstockt, B., Fiocchi, C., Torres, J., & Scharl, M. M. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab051 · Cited by 58
Huang, M., Ji, Q., Huang, H., Wang, X., & Wang, L. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2486519 · Cited by 57
“99,100 Moreover, Bacteroides fragilis has been found to produce OMVs containing capsular PSA, which increases IL-10 expression in Tregs and activates TLR2 signaling in both T cells and DCs. 101,102 SCFAs also play a role in regulating the number and functionality of Tregs.”
Barteneva, N. S., Baiken, Y., Fasler-Kan, E., Alibek, K., Wang, S., Maltsev, N., Ponomarev, E. D., Sautbayeva, Z., Kauanova, S., Moore, A., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.06.005 · Cited by 50
“Recently, Chu and co-authors [264], demonstrated that bMVs shed by B.”
Remke, M., Groll, T., Metzler, T., Urbauer, E., Kövilein, J., Schnalzger, T., Ruland, J., Haller, D., & Steiger, K. (2024) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2024.104938 · Cited by 58
Mechanistic insight into the gut microbiome and its interaction with host immunity and inflammation
Xue, J., Ajuwon, K. M., & Fang, R. (2020) · Animal nutrition · doi:10.1016/j.aninu.2020.05.007 · Cited by 54
“The capsular polysaccharide A can also directly activate TLR2 signal pathway to restrain the immune response induced by Th17 cells (Chu et al., 2016; Joller et al., 2014).”
BackgroundMicrobial sensing in the intestine
Wan, T., Wang, Y., He, K., & Zhu, S. (2023) · Protein & Cell · doi:10.1093/procel/pwad028 · Cited by 51
Zeng, L., Yu, G., Yang, K., Wang, X., Li, J., & Chen, H. (2022) · Stem Cells International · doi:10.1155/2022/9463314 · Cited by 63
Zhou, S., Cui, Y., Zhang, Y., Zhao, T., & Cong, J. (2023) · International Journal of Colorectal Disease · doi:10.1007/s00384-023-04354-4 · Cited by 55
NOD1 and NOD2: Molecular targets in prevention and treatment of infectious diseases
Pashenkov, M. V., Dagil, Y. A., & Pinegin, B. V. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.11.036 · Cited by 56
Role of Inflammation in Pathophysiology of Colonic Disease: An Update
Nasef, N. A., & Mehta, S. Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134748 · Cited by 49
Evaluation of the Effects of Different Bacteroides vulgatus Strains against DSS-Induced Colitis
Li, S., Wang, C., Zhang, C., Luo, Y., Cheng, Q., Yu, L., & Sun, Z. (2021) · Journal of Immunology Research · doi:10.1155/2021/9117805 · Cited by 51
Clement, M., Raffort, J., Lareyre, F., Tsiantoulas, D., Newland, S., Lu, Y., Masters, L., Harrison, J., Saveljeva, S., Ma, M. K. L., et al. (2019) · Circulation Research · doi:10.1161/circresaha.119.315248 · Cited by 44
“Chu et al 36 reported reduced in vitro generation of IL10 + Foxp3 + Tregs in the presence of Atg16l1 deficient versus WT bone marrow monocyte-derived DCs when the cells were incubated with outer membrane vesicles harvested from Bacteroides fragilis .”
Sharpton, T., Lyalina, S., Luong, J., Pham, J., Deal, E. M., Armour, C., Gaulke, C., Sanjabi, S., & Pollard, K. S. (2017) · mSystems · doi:10.1128/msystems.00036-17 · Cited by 45
“A similar loss of Tregs occurs in people with polymorphisms in IBD-susceptibility 74 genes that promote defects in Treg responses (19).”
BackgroundFecal Microbiota Transplantation: From Clostridium difficile to Inflammatory Bowel Disease.
Gianotti, R. J., & Moss, A. C. (2017) · Europe PMC (PubMed Central) · Cited by 52
Inflammatory bowel disease–associated intestinal fibrosis
Park, J. M., Kim, J., Lee, Y. J., Bae, S. U., & Lee, H. W. (2023) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2022.11.02 · Cited by 45
“The stability of the intestinal microbiota supports the barrier function of intestinal epithelial cells [56].”
Niu, G., Jian, T., Gai, Y., & Chen, J. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114774 · Cited by 47
A bacterial sialidase mediates early-life colonization by a pioneering gut commensal
Buzun, E., Hsu, C.-Y., Sejane, K., Oles, R. E., Ayala, A. V., Loomis, L. R., Zhao, J., Rossitto, L.-A. M., McGrosso, D., Gonzalez, D. J., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2023.12.014 · Cited by 49
Self-citationDong, X., Qi, M., Cai, C., Zhu, Y., Li, Y., Coulter, S., Sun, F., Liddle, C., Uboha, N. V., Halberg, R. B., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.170428 · Cited by 51
Bacterial extracellular vesicles: Vital contributors to physiology from bacteria to host
Nie, X., Li, Q., Chen, X., Onyango, S. O., Xie, J., & Nie, S. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127733 · Cited by 52
Conjugation of ATG8s to single membranes at a glance
Figueras-Novoa, C., Timimi, L., Marcassa, E., Ulferts, R., & Beale, R. C. L. (2024) · Journal of Cell Science · doi:10.1242/jcs.261031 · Cited by 52
A system biology perspective on environment–host–microbe interactions
Chen, L., Garmaeva, S., Zhernakova, A., Fu, J., & Wijmenga, C. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy137 · Cited by 53
Kameli, N., Borman, R., López‐Iglesias, C., Savelkoul, P. H. M., & Stassen, F. R. M. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.667987 · Cited by 53
“This is supported by recent studies which investigated the immunoregulatory role of MVs and showed pro- as well as anti-inflammatory effects of these MVs (Shen et al., 2012; Hickey et al., 2015; Chu et al., 2016; Durant et al., 2020).”
ResultLactate-utilizing bacteria ameliorates DSS-induced colitis in mice
Chen, L., Li, R., Wang, Z., Zhang, Z., Wang, J., Qiao, Y., Huang, Y., & Liu, W. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120179 · Cited by 49
Thromboembolic Events in Patients with Inflammatory Bowel Disease: A Comprehensive Overview
Gala, D., Newsome, T., Roberson, N., Lee, S. M., Thekkanal, M., Shah, M., Kumar, V., Bandaru, P. K. R., & Gayam, V. B. R. (2022) · Diseases · doi:10.3390/diseases10040073 · Cited by 47
“fragilis is increased in the microbiota but is pro-inflammatory by inhibiting T-lymphocyte development [32].”
BackgroundLuo, X., Wang, X., Huang, S., Xu, B., Luo, S., Li, Y., Wang, Q., Chen, Y., Deng, X., Liu, L., et al. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107224 · Cited by 45
Microbial and genetic-based framework identifies drug targets in inflammatory bowel disease
Wang, Z., Guo, K., Gao, P., Pu, Q., Lin, P., Qin, S., Xie, N., Hur, J., Li, C. L., Huang, C., et al. (2021) · Theranostics · doi:10.7150/thno.59196 · Cited by 43
“Moreover, NOD2 and ATG16L1 are required for human commensal Bacteroides fragilis-mediated protection from colitis [9].”
BackgroundCeliberto, L. S., Bedani, R., Dejani, N. N., de Medeiros, A. I., Zuanon, J. A. S., Spolidório, L. C., Adorno, M. Â. T., Varesche, M. B. A., Galvão, F. C., Valentini, S. R., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175935 · Cited by 51
SALSA—A dance on a slippery floor with changing partners
Reichhardt, M. P., Holmskov, U., & Meri, S. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.05.029 · Cited by 47
Chen, F., Yin, Y., Zhao, H., Wang, H.-Y., Zhong, Y., Long, J., & Liu, D. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00801 · Cited by 42
Luo, R., Chang, Y., Liang, H., Zhang, W., Song, Y., Li, G., & Cao, Y. (2023) · iMeta · doi:10.1002/imt2.86 · Cited by 47
“…in the case of the human commensal Bacteroides fragilis regulating the human immune response, purified BEVs delivered to intestinal dendritic cells exhibit anti ‐ inflammatory effects by promoting IL ‐ 10 production and reducing IL ‐ 17A expression from CD4+ Foxp3+ regulatory T cells [151].”
BackgroundGene–environment interactions shape the host–microbial interface in inflammatory bowel disease
Cadwell, K., & Loke, P. (2025) · Nature Immunology · doi:10.1038/s41590-025-02197-5 · Cited by 46
“In a NOD2-and ATG16L1-dependent manner, outer membrane vesicles from the commensal bacterium Bacteroides fragilis induce an autophagy-like pathway that biases dendritic cells toward a tolerogenic state, favoring differentiation of T reg cells that dampen intestinal inflammation 48 .”
Atopic Dermatitis Susceptibility Variants in Filaggrin Hitchhike Hornerin Selective Sweep
Eaaswarkhanth, M., Xu, D., Flanagan, C., Rzhetskaya, M., Hayes, M. G., Blekhman, R., Jablonski, N. G., & Gökçümen, Ö. (2016) · Genome Biology and Evolution · doi:10.1093/gbe/evw242 · Cited by 45
The intrinsic and extrinsic elements regulating inflammation
Mollaei, M., Abbasi, A., Hassan, Z. M., & Pakravan, N. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118258 · Cited by 44
Nelson, A., Stewart, C. J., Kennedy, N. A., Lodge, J. K., Tremelling, M., Probert, C. S., Parkes, M., Mansfield, J. C., Smith, D., Hold, G. L., et al. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa220 · Cited by 44
Hou, J., Zhao, M., Zou, A., Zhu, X., Fu, R., & Xianyu, Y. (2025) · Advanced Materials · doi:10.1002/adma.202508754 · Cited by 47
Lamprinaki, D., Beasy, G., Zhekova, A., Wittmann, A., James, S. A., Dicks, J. L., Iwakura, Y., Saijo, S., Wang, X., Chow, C., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01397 · Cited by 41
“Autophagy-active and LAP-deficient DCs failed to induce regulatory T cells in response to OMVs secreted from a commensal bacteria Bacteroides fragilis (41).”
BackgroundWang, M., Chen, Y., Wang, Y., Li, Y., Zhang, X., Zheng, H., Ma, F., Ma, C., Lu, B., Xie, Z., et al. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.07.008 · Cited by 43
LncRNA CDKN2B-AS1 relieved inflammation of ulcerative colitis via sponging miR-16 and miR-195
Tian, Y., Cui, L., Lin, C., Wang, Y., Liu, Z., & Miao, X. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106970 · Cited by 42
Probiotic-Induced Tolerogenic Dendritic Cells: A Novel Therapy for Inflammatory Bowel Disease?
Ghavami, S. B., Aghdaei, H. A., Sorrentino, D. R., Shahrokh, S., Farmani, M., Ashrafian, F., Dore, M. P., Raftar, S. K. A., Khoramjoo, S. M., & Zali, M. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158274 · Cited by 41
Moody microbiome: Challenges and chances
Kuo, P.-H., & Chung, Y.-C. E. (2019) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.09.004 · Cited by 40
From trash to treasure: the role of bacterial extracellular vesicles in gut health and disease
Sun, D., Chen, P., Xi, Y., & Sheng, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1274295 · Cited by 47
“Current research indicates that BEVs contribute to IBD via damaging both physical and immune barriers, particularly the epithelial and immune cells (Figure 3A).”
BackgroundInfluentialRevisiting the Role of Valeric Acid in Manipulating Ulcerative Colitis
Liu, M., Zhang, Y., Liu, J., Xiang, C., Lu, Q., Lu, H., Yang, T., Wang, X., Zhang, Q., Fan, C., et al. (2024) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izad187 · Cited by 41
Roles of bacterial extracellular vesicles in systemic diseases
Wang, Y., Luo, X., Xiang, X., Hao, C., & Ma, D. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1258860 · Cited by 48
“…that focused on the effects of BEVs on the mucosal immune system showed that the uptake of B. fragilis OMVs by dendritic cells (DCs) induced regulatory T cells (Tregs), and Bacteroides thetaiotaomicron OMVs also exerted an effect on T-cell functions (Chu et al., 2016; Wegorzewska et al., 2019).”
BackgroundLi, J., Lu, Y., Wang, D., Quan, F., Chen, X., Sun, R., Zhao, S., Yang, Z., Tao, W., Ding, D., et al. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.03.059 · Cited by 39
Microbial modulation of intestinal T helper cell responses and implications for disease and therapy
Geuking, M. B., & Burkhard, R. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-00335-w · Cited by 39
Gao, J., Cao, B., Zhao, R., Li, H., Xu, Q., & Wei, B. (2023) · Pharmaceuticals · doi:10.3390/ph16091216 · Cited by 41
“Many factors related to intestinal barrier damage have been reported, such as ischemia-reperfusion (I/R) injury [3], mental disorders [4], inflammatory mediators [5], microbiota dysbiosis [6], an unhealthy diet [7], bacterialderived endotoxin [8], immune abnormalities [9], and ionizing radiation [10].”
BackgroundBMSC-EVs regulate Th17 cell differentiation in UC via H3K27me3
Chen, Q., Duan, X., Xu, M., Fan, H., Dong, Y., Wu, H., Zhang, M., Liu, Y., Nan, Z., Deng, S., et al. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.12.019 · Cited by 38
Tapias, N. S., Vergnolle, N., Denadai‐Souza, A., & Barreau, F. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa033 · Cited by 41
Wood, T. E., Aksoy, E., & Hachani, A. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.587948 · Cited by 46
“Mucosal DCs interacting with commensal bacterial components directly or through indirect acquisition of secreted outer membrane vesicles (OMVs) prime host regulatory T cells (Tregs), a subset of T cells promoting tolerance to both food and microbial antigens, thus dampening immune responses to the resident bacterial c…”
BackgroundZheng, W., Miao, J., Luo, L., Long, G., Chen, B., Shu, X., Gu, W., Peng, K., Li, F., Zhao, H., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.625586 · Cited by 43
“Emerging evidence have shown that intestinal microbiota plays a fundamental role in regulating inflammatory responses by inducing local regulation of T cell differentiation that inhibits inflammatory response (17, 18).”
BackgroundRecent advances in gut immunology
Powell, N., & MacDonald, T. T. (2017) · Parasite Immunology · doi:10.1111/pim.12430 · Cited by 35
Zakrzewski, M., Simms, L. A., Brown, A., Appleyard, M. N., Irwin, J. R., Waddell, N., & Radford‐Smith, G. L. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy188 · Cited by 34
Wu, J., Li, H., Xie, H., Wu, X., & Lan, P. (2019) · Carcinogenesis · doi:10.1093/carcin/bgy138 · Cited by 42
Preventative delivery of IL-35 by Lactococcus lactis ameliorates DSS-induced colitis in mice
Wang, J., Tian, M., Li, W., & Hao, F. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10094-9 · Cited by 40
Structure and assembly of type VI secretion system cargo delivery vehicle
He, W., Wu, K., Ouyang, Z., Bai, Y., Luo, W., Wu, D., An, H., Guo, Y.-C., Jiao, M., Qin, Q., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112781 · Cited by 39
The gut mucus network: A dynamic liaison between microbes and the immune system
Inaba, R., Vujakovic, S., & Bergstrom, K. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101807 · Cited by 45
Dong, F., Hao, L., Wang, L., & Huang, Y. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.07.064 · Cited by 41
Dunn, K. A., Moore-Connors, J., MacIntyre, B., Stadnyk, A. W., Thomas, N. A., Noble, A. J., Mahdi, G., Rashid, M., Otley, A. R., Bielawski, J. P., et al. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000949 · Cited by 37
Jeon, S. R., Chai, J., Kim, C., & Lee, C. (2018) · Current Infectious Disease Reports · doi:10.1007/s11908-018-0627-8 · Cited by 36
Urban colonization through multiple genetic lenses: The city‐fox phenomenon revisited
DeCandia, A. L., Brzeski, K. E., Heppenheimer, E., Caro, C. V., Camenisch, G., Wandeler, P., Driscoll, C., & vonHoldt, B. M. (2019) · Ecology and Evolution · doi:10.1002/ece3.4898 · Cited by 35
The Macroautophagy Machinery in MHC Restricted Antigen Presentation
Münz, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.628429 · Cited by 38
“Bacterial outer membrane vesicles (OMVs) might also be processed via this LAP for regulatory CD4 T cell stimulation (49).”
BackgroundZhang, S., Fu, J., Dogan, B., Scherl, E., & Simpson, K. W. (2018) · The Journal of Antibiotics · doi:10.1038/s41429-018-0081-8 · Cited by 38
Gonçalves, M. F. M., Pina‐Vaz, T., Fernandes, Â. R., Miranda, I. M., Silva, C., Rodrigues, A. G., & Lisboa, C. (2023) · Cancers · doi:10.3390/cancers15051423 · Cited by 33
Bacterial extracellular vesicles for gut microbiome–host communication and drug development
Qian, D., Xu, P., Wang, X., Du, C., Zhao, X., & Xu, J. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.03.008 · Cited by 41
Bacteroides sphingolipids promote anti-inflammatory responses through the mevalonate pathway
Brown, E., Temple, E. R., Jeanfavre, S., Ávila-Pacheco, J., Taylor, N., Liu, K., Nguyen, P. N. U., Mohamed, A. M., Ung, P., Walker, R. A., et al. (2025) · Cell Host & Microbe · doi:10.1016/j.chom.2025.05.007 · Cited by 40
Self-citationBalasubramanian, I., & Gao, N. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00330.2016 · Cited by 38
Petakh, P., Kamyshna, I. I., Nykyforuk, A., Yao, R., Imbery, J. F., Oksenych, V., Korda, M. M., & Kamyshnyi, O. (2022) · Viruses · doi:10.3390/v14030477 · Cited by 36
“This is accomplished by promoting the differentiation and activation of immune cells, such as T helper 1 (Th1), Th2, dendritic cells (DCs), and macrophages [17].”
BackgroundInfluentialHow autophagy, a potential therapeutic target, regulates intestinal inflammation
Chen, S.-L., Li, C., Li, W., Liu, Q., Hu, S., Zhao, M., Hu, D.-S., Hao, Y., Zeng, J., & Zhang, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1087677 · Cited by 43
Genetic control of autophagy underlies pathogenesis of inflammatory bowel disease
Lassen, K. G., & Xavier, R. J. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.18 · Cited by 33
“Recent studies have also found that microbiome-derived outer membrane vesicles, which are often shed in the intestinal lumen, are inefficient at inducing regulatory T cells to suppress inflammation and promote microbial tolerance in mice and humans that harbor the ATG16L1 T300A polymorphism.(108) Finally, ATG16L1 T300…”
BackgroundSelf-citationAutophagy: A Novel Mechanism Involved in the Anti-Inflammatory Abilities of Probiotics
Zaylaa, M., Alard, J., Kassaa, I. A., Peucelle, V., Boutillier, D., Desramaut, J., Rosenstiel, P. C., Nguyen, H. T. T., Dabboussi, F., Pot, B., et al. (2019) · Cellular Physiology and Biochemistry · doi:10.33594/000000172 · Cited by 33
Liu, T., Tao, W.-C., Liang, Q., Tu, W.-Q., Xiao, Y., & Chen, L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.585995 · Cited by 32
Microbiome, pattern recognition receptor function in health and inflammation
Fawkner-Corbett, D., Simmons, A., & Parikh, K. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.11.001 · Cited by 35
Autophagy: A potential target for natural products in the treatment of ulcerative colitis
Zhang, W., Zou, M., Fu, J., Xu, Y., & Zhu, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116891 · Cited by 33
Chen, X., Feng, Y., Zhang, D., Zhou, S., Liu, X., Luo, B., Zhou, C., & Liu, M. (2025) · Nano Today · doi:10.1016/j.nantod.2025.102669 · Cited by 31
Metabolic Dependencies Underlie Interaction Patterns of Gut Microbiota During Enteropathogenesis
Dai, D., Wang, T., Wu, S., Gao, N., & Chen, W. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01205 · Cited by 30
“, 2018) including inflammatory bowel disease (IBD; Joossens et al., 2011; Matsuoka and Kanai, 2015; Chu et al., 2016; Sartor and Wu, 2017; Zuo and Ng, 2018), type 2 diabetes (Delzenne et al.”
BackgroundMa, Z., Yu, Z., Hu, C., & Yi, H. (2019) · Frontiers in Immunology · doi:10.2139/ssrn.3441816 · Cited by 32
Duan, C., Tang, X., Wang, W., Qian, W., Fu, X., Deng, X., Zhou, S., Han, C., & Hou, X. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4780 · Cited by 31
“The microbiota in the human intestine may be closely related to the development of IBD via their influence on the physiological functions of the colorectum (3-5).”
Kang, M., Lee, S., Park, Y. M., Kim, B. S., Lee, M.-J., Kim, J., Jeong, S., Lee, S., Park, M. J., Rhee, E. S., et al. (2021) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2021.13.3.404 · Cited by 33
Cardiovascular implications of inflammatory bowel disease: An updated review
Bhardwaj, A., Singh, A., Midha, V., Sood, A., Wander, G. S., Mohan, B., & Batta, A. (2023) · World Journal of Cardiology · doi:10.4330/wjc.v15.i11.553 · Cited by 33
Development of an XBP1 agonist, HLJ2, as a potential therapeutic agent for ulcerative colitis
Zhang, H., Zhang, Z., Song, G., Tang, X., Song, H., Deng, A., Wang, W., Wu, L., & Qin, H. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.07.028 · Cited by 30
Metadata
- Authors
- Chu, H., Khosravi, A., Kusumawardhani, I. P., Kwon, A. H. K., Vasconcelos, A. C., Cunha, L. D., Mayer, A. E., Shen, Y., Wu, W.-L., Kambal, A., Targan, S. R., Xavier, R. J., Ernst, P. B., Green, D. R., McGovern, D. P. B., Virgin, H. W., & Mazmanian, S. K.
- Affiliations
- California Institute of Technology (US)
- University of California San Diego (US)
- St. Jude Children's Research Hospital (US)
- Washington University in St. Louis (US)
- Cedars-Sinai Medical Center (US)
- Harvard University (US)
- Corresponding author
- Chu, Hiutung
- Mazmanian, Sarkis K.
- ORCID
- Venue
- Science
- Published
- 2016-05-27
- Volume
- 352
- Issue
- 6289
- Pages
- 1116-1120
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC4996125
- OpenAlex
- W2346233234
- Cited by
- 647
- References
- 48
- Citations by year
- 2026: 50 · 2025: 55 · 2024: 60 · 2023: 64 · 2022: 57 · 2021: 69 · 2020: 68 · 2019: 77 · 2018: 56 · 2017: 65 · 2016: 24
- FWCI
- 59.72
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Funders
- National Institutes of Health (NIH)
- Ruth L. Kirschtein National Research Service Award (DK100109)
- Cedars-Sinai F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute Research Funds
- Feintech Family Chair
- Wayne and Gladys Valley Foundation
- Lupus Research Institute
- Lisa Z. Greer Endowed Chair
- European Union (305479)
- Leona M. and Harry B. Helmsley Charitable Trust
- NIH (DK097485, PO1DK046763, AI079145, AI40646, U19 AI109725, DK062413, DE023789-01, AI109725, DK078938, GM099535)
- Crohn's and Colitis Foundation of America
- Heritage Medical Research Institute
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- inflammatory bowel disease, Bacteroides fragilis, outer membrane vesicles, ATG16L1, NOD2, non-canonical autophagy, dendritic cells, regulatory T cells, colitis, gut dysbiosis, susceptibility genes, mucosal inflammation
- MeSH terms
- Extracellular Vesicles, Gastrointestinal Microbiome, Autophagy-Related Proteins, Adult, Aged, Animals, Autophagy, Bacteroides fragilis, Carrier Proteins, Dendritic Cells, Female, Humans, Intestinal Mucosa, Male, Mice, Inbred C57BL, Middle Aged, Polymorphism, Genetic, Inflammatory Bowel Diseases, Genome, Human, Genetic Predisposition to Disease, T-Lymphocytes, Regulatory, Mice, Nod2 Signaling Adaptor Protein, Gene-Environment Interaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.